310 related articles for article (PubMed ID: 30554964)
1. Human ESC-Derived Chimeric Mouse Models of Huntington's Disease Reveal Cell-Intrinsic Defects in Glial Progenitor Cell Differentiation.
Osipovitch M; Asenjo Martinez A; Mariani JN; Cornwell A; Dhaliwal S; Zou L; Chandler-Militello D; Wang S; Li X; Benraiss SJ; Agate R; Lampp A; Benraiss A; Windrem MS; Goldman SA
Cell Stem Cell; 2019 Jan; 24(1):107-122.e7. PubMed ID: 30554964
[TBL] [Abstract][Full Text] [Related]
2. Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease.
Benraiss A; Mariani JN; Osipovitch M; Cornwell A; Windrem MS; Villanueva CB; Chandler-Militello D; Goldman SA
Cell Rep; 2021 Jul; 36(1):109308. PubMed ID: 34233199
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
5. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.
Benraiss A; Wang S; Herrlinger S; Li X; Chandler-Militello D; Mauceri J; Burm HB; Toner M; Osipovitch M; Jim Xu Q; Ding F; Wang F; Kang N; Kang J; Curtin PC; Brunner D; Windrem MS; Munoz-Sanjuan I; Nedergaard M; Goldman SA
Nat Commun; 2016 Jun; 7():11758. PubMed ID: 27273432
[TBL] [Abstract][Full Text] [Related]
6. Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain.
Vieira R; Mariani JN; Huynh NPT; Stephensen HJT; Solly R; Tate A; Schanz S; Cotrupi N; Mousaei M; Sporring J; Benraiss A; Goldman SA
Nat Biotechnol; 2024 May; 42(5):719-730. PubMed ID: 37460676
[TBL] [Abstract][Full Text] [Related]
7. Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia.
Windrem MS; Osipovitch M; Liu Z; Bates J; Chandler-Militello D; Zou L; Munir J; Schanz S; McCoy K; Miller RH; Wang S; Nedergaard M; Findling RL; Tesar PJ; Goldman SA
Cell Stem Cell; 2017 Aug; 21(2):195-208.e6. PubMed ID: 28736215
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.
Ferrari Bardile C; Garcia-Miralles M; Caron NS; Rayan NA; Langley SR; Harmston N; Rondelli AM; Teo RTY; Waltl S; Anderson LM; Bae HG; Jung S; Williams A; Prabhakar S; Petretto E; Hayden MR; Pouladi MA
Proc Natl Acad Sci U S A; 2019 May; 116(19):9622-9627. PubMed ID: 31015293
[TBL] [Abstract][Full Text] [Related]
9. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
10. Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a
Davis GH; Zaya A; Pearce MMP
J Neurosci; 2024 May; 44(20):. PubMed ID: 38589228
[TBL] [Abstract][Full Text] [Related]
11. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
12. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
[TBL] [Abstract][Full Text] [Related]
13. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.
Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA
Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381
[TBL] [Abstract][Full Text] [Related]
14. Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2016 Aug; 36(34):8790-801. PubMed ID: 27559163
[TBL] [Abstract][Full Text] [Related]
15. Human Glial Progenitor Cells Effectively Remyelinate the Demyelinated Adult Brain.
Windrem MS; Schanz SJ; Zou L; Chandler-Militello D; Kuypers NJ; Nedergaard M; Lu Y; Mariani JN; Goldman SA
Cell Rep; 2020 May; 31(7):107658. PubMed ID: 32433967
[TBL] [Abstract][Full Text] [Related]
16. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic contributions to Huntington's disease pathophysiology.
Khakh BS; Goldman SA
Ann N Y Acad Sci; 2023 Apr; 1522(1):42-59. PubMed ID: 36864567
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
Ban JJ; Chung JY; Lee M; Im W; Kim M
Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte molecular signatures in Huntington's disease.
Diaz-Castro B; Gangwani MR; Yu X; Coppola G; Khakh BS
Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619545
[TBL] [Abstract][Full Text] [Related]
20. Human Glial Chimeric Mice to Define the Role of Glial Pathology in Human Disease.
Mariani JN; Zou L; Goldman SA
Methods Mol Biol; 2019; 1936():311-331. PubMed ID: 30820907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
